throbber

`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`1
`
`·1· · · · · · UNITED STATES PATENT AND TRADEMARK OFFICE
`
`·2· · · · · · ·BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`·3
`
`·4· ·JUBILANT DRAXIMAGE, INC.,
`
`·5· · · · · · · · · · ·Petitioner,
`
`·6· · · · · · · vs.
`
`·7
`
`·8· ·BRACCO DIAGNOSTICS, INC.,
`
`·9· · · · · · · · · · ·Patent Owner.
`
`10· ·_____________________________
`
`11
`
`12
`
`13
`
`14
`
`15· · · · · · · ·IPRs2018-01448, -01449, and -01450
`
`16· · · · · · ·U.S. Patent Nos. 9,229,467 and 9,229,468
`
`17
`
`18
`
`19
`
`20· · · · The Deposition of VENKATESH MURTHY, M.D.,
`
`21· · · · Taken at 900 Victors Way, Suite 261,
`
`22· · · · Ann Arbor, Michigan,
`
`23· · · · Commencing at 9:01 a.m.,
`
`24· · · · Thursday, May 23, 2019,
`
`25· · · · Before Lezlie A. Setchell, CSR-2404, RPR, CRR.
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`Bracco Ex. 2016
`Jubilant v. Bracco
`IPR2018-01449
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`2
`
`·1· ·APPEARANCES:
`
`·2
`
`·3· ·T. CY WALKER
`
`·4· ·BakerHostetler, LLP
`
`·5· ·Washington Square, Suite 1100
`
`·6· ·1050 Connecticut Avenue, N.W.
`
`·7· ·Washington, DC 20036-5304
`
`·8· ·202.861.1688
`
`·9· ·cwalker@bakerlaw.com
`
`10· · · · Appearing on behalf of the Petitioner.
`
`11
`
`12· ·BARRY J. SCHINDLER
`
`13· ·GreenbergTraurig, LLP
`
`14· ·500 Campus Drive
`
`15· ·Suite 400
`
`16· ·Florham Park, New Jersey 07932-0677
`
`17· ·973.360.7944
`
`18· ·schindlerb@gtlaw.com
`
`19· · · · Appearing on behalf of the Patent Owner.
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`3
`
`·1· · · · · · · · · · ·TABLE OF CONTENTS
`
`·2
`
`·3· · WITNESS· · · · · · · · · · · · · · · · · PAGE
`
`·4· · VENKATESH MURTHY, M.D.
`
`·5
`
`·6· · EXAMINATION
`
`·7· · BY MR. SCHINDLER· · · · · · · · · · · · · 4
`
`·8· · EXAMINATION
`
`·9· · BY MR. WALKER· · · · · · · · · · · · · · 42
`
`10
`
`11· · · · · · · · · · · · ·EXHIBITS
`
`12
`
`13· · EXHIBIT· · · · · · · · · · · · · · · · · PAGE
`
`14· · (Exhibits attached to transcript.)
`
`15
`
`16· · EXHIBIT 1001· · · · · · · · · · · · · · · 6
`
`17· · Declaration of Venkatesh L.
`
`18· · Murthy, M.D., Ph.D.
`
`19· · EXHIBIT 1002· · · · · · · · · · · · · · ·42
`
`20· · Bracco CardioGen-82
`
`21· · Infusion System
`
`22· · User's Guide
`
`23
`
`24
`
`25
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`4
`
`·1· ·Ann Arbor, Michigan
`
`·2· ·Thursday, May 23, 2019
`
`·3· ·9:01 a.m.
`
`·4· · · · · · · · · · ·VENKATESH MURTHY, M.D.,
`
`·5· · · · was thereupon called as a witness herein, and after
`
`·6· · · · having first been duly sworn to testify to the truth,
`
`·7· · · · the whole truth and nothing but the truth, was
`
`·8· · · · examined and testified as follows:
`
`·9
`
`10· · · · · · · · · · · · · ·EXAMINATION
`
`11· ·BY MR. SCHINDLER:
`
`12· ·Q.· ·Good morning, Doctor.· My name is Barry Schindler, and
`
`13· · · · I represent Bracco Diagnostics in the case before the
`
`14· · · · U.S. Patent Office.· I actually see before you a
`
`15· · · · Declaration that you had executed in this proceeding;
`
`16· · · · is that correct?
`
`17· ·A.· ·Yes.
`
`18· ·Q.· ·So I actually have a copy, also, of that Declaration,
`
`19· · · · but I gather if you want to use your own, would that
`
`20· · · · be more comfortable for you?
`
`21· ·A.· ·Yes.· I actually have a couple of minor corrections of
`
`22· · · · typos and things.
`
`23· ·Q.· ·Excellent.· So we'll get there.· Before we get there,
`
`24· · · · as I understand that previously that you have had your
`
`25· · · · deposition taken at least twice now I believe?
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`5
`
`·1· ·A.· ·This will be my third deposition, yeah.
`
`·2· ·Q.· ·And you've also appeared at an ITC trial?
`
`·3· ·A.· ·Yep, that was my first time in court.
`
`·4· ·Q.· ·Okay.· So I understand then that you understand sort
`
`·5· · · · of the basic ground rules, and the ground rules are,
`
`·6· · · · one, I will ask you a question.· You will wait until I
`
`·7· · · · finish my question.· Is that okay?
`
`·8· ·A.· ·Yes.
`
`·9· ·Q.· ·And then you will answer, I will wait until you
`
`10· · · · answer, and I will not interrupt you.· Do you
`
`11· · · · understand that?
`
`12· ·A.· ·Yes.
`
`13· ·Q.· ·Second, if you don't understand the question, you will
`
`14· · · · ask me if you don't understand.· Otherwise, I will
`
`15· · · · assume you understood my question, correct?
`
`16· ·A.· ·Okay.
`
`17· ·Q.· ·And if you need to take a break at any time, just say
`
`18· · · · I need to take a break; do you understand that?
`
`19· ·A.· ·Understood.
`
`20· · · · · · · · · ·MR. SCHINDLER:· Actually, let's do some
`
`21· · · · what we'll call the administrative part first. I
`
`22· · · · understand you said you had some typos.· So I'm going
`
`23· · · · to use as Jubilant Exhibit 1017, which is the
`
`24· · · · Declaration you executed, and on this I'm going to use
`
`25· · · · a red pen, and I would like you to mark up in red pen
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`6
`
`·1· · · · --
`
`·2· · · · · · · · · ·Actually, let's mark this as an exhibit.
`
`·3· · · · · · · · · ·MARKED FOR IDENTIFICATION:
`
`·4· · · · · · · · · ·EXHIBIT 1001
`
`·5· · · · · · · · · ·Declaration of Venkatesh L.
`
`·6· · · · · · · · · ·Murthy, M.D., Ph.D.
`
`·7· · · · · · · · · ·9:04 a.m.
`
`·8· ·BY MR. SCHINDLER:
`
`·9· ·Q.· ·So I'm going to hand you Murthy Exhibit 1001, and I'm
`
`10· · · · going to hand you a red pen, and you can walk me
`
`11· · · · through the typographical or other errors.
`
`12· ·A.· ·Okay.· Happy to.· Page 3, paragraph 5, sentence that
`
`13· · · · starts with "I have personal experience working with
`
`14· · · · rubidium-82 elution system" -- excuse me, sorry, the
`
`15· · · · next sentence -- "I first started working with
`
`16· · · · rubidium-82 elution systems during my time at Brigham
`
`17· · · · and Women's Hospital."
`
`18· · · · · · · · · ·So insert the word "time" between "my" and
`
`19· · · · "at".
`
`20· ·Q.· ·Excellent.
`
`21· ·A.· ·Page 12, paragraph 28, the reference for the sentence
`
`22· · · · that says:· "Since at least as early as the 1990s, the
`
`23· · · · US Pharmacopeia has included radionucleic purity
`
`24· · · · specifications for rubidium chloride injections."
`
`25· · · · · · · · · ·That should be "to US Pharmacopeia 23
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`7
`
`·1· · · · National Formulary 18 (1995)."· Refer to it as USP23.
`
`·2· ·Q.· ·So just to be clear, where it says 100O at 1392, that
`
`·3· · · · should be stricken out?
`
`·4· ·A.· ·Correct.
`
`·5· ·Q.· ·So if you'll write that in.
`
`·6· · · · · · · · · ·MR. WALKER:· At 1392 probably still should
`
`·7· · · · be there?
`
`·8· · · · · · · · · ·THE WITNESS:· Yes, that's correct.
`
`·9· · · · · · · · · ·Page 16, paragraph 35, the sentence:· "By
`
`10· · · · 2008, it was common to --" insert the word "to"
`
`11· · · · between "common" and "use" -- "common to use bar codes
`
`12· · · · to track --" and then strike the word "to" after the
`
`13· · · · word "track --" "to track a variety of healthcare
`
`14· · · · assets."
`
`15· ·BY MR. SCHINDLER:
`
`16· ·Q.· ·Excellent.
`
`17· ·A.· ·I'll just confirm that there's nothing else.
`
`18· · · · · · · · · ·That will be all.
`
`19· · · · · · · · · ·MR. SCHINDLER:· Thank you.· Just for the
`
`20· · · · record, again, the witness has in Exhibit 1001 in red
`
`21· · · · pen made a series of changes or grammatical changes,
`
`22· · · · and this is noted in the Exhibit 1001.
`
`23· ·BY MR. SCHINDLER:
`
`24· ·Q.· ·So let me also have some nomenclature we're going to
`
`25· · · · use.· You understand this says Declaration of
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`8
`
`·1· · · · Dr. Murthy?
`
`·2· ·A.· ·Correct.
`
`·3· ·Q.· ·And it also says Jubilant Exhibit 1017?
`
`·4· ·A.· ·Correct.
`
`·5· ·Q.· ·During the deposition when I refer to either your
`
`·6· · · · Declaration or Jubilant Exhibit 1017, please
`
`·7· · · · understand it is the same document.
`
`·8· ·A.· ·Thank you.
`
`·9· ·Q.· ·That being said, let's stay in your Declaration, and
`
`10· · · · let's go to the page where you executed, page 1717.
`
`11· · · · Now as I understand, you executed this Declaration on
`
`12· · · · August 14th of 2018, correct?
`
`13· ·A.· ·That's the date that's written there.· I assume that
`
`14· · · · was correct.
`
`15· ·Q.· ·Okay.· You have no reason to doubt that date?
`
`16· ·A.· ·No.
`
`17· ·Q.· ·So let's put ourselves in that timeframe.· So prior to
`
`18· · · · August 14 of 2018, did you have any discussions with
`
`19· · · · Dr. Robert Stone?
`
`20· ·A.· ·No, I have not, no.· I don't recall ever speaking with
`
`21· · · · him before that time.
`
`22· ·Q.· ·I gather after that time you did speak to Robert
`
`23· · · · Stone?
`
`24· ·A.· ·I think in the preparation period for the ITC hearing,
`
`25· · · · he may have been one of the people that I shook hands
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`9
`
`·1· · · · with and said hello to, but I don't believe I've ever
`
`·2· · · · had a substantive discussion other than a social, you
`
`·3· · · · know, introduction.
`
`·4· ·Q.· ·Okay.· Did you prior to executing on August 14 of 2018
`
`·5· · · · have any discussion with a Ran Klein?
`
`·6· ·A.· ·I've known Ran Klein for many years.· He's a prominent
`
`·7· · · · person in the field of nuclear cardiology, and I've
`
`·8· · · · met with him at a number of professional society
`
`·9· · · · meetings, and I've read his work published in many
`
`10· · · · journals.· I've seen his lectures at various fora.
`
`11· · · · So, yes, I've met with him multiple times.
`
`12· ·Q.· ·So now if you turn to page 5 of your Declaration, you
`
`13· · · · see on page 5 you reference several publications.· One
`
`14· · · · of them is to a Klein and it's a February, 2005.· Do
`
`15· · · · you understand that is the same Ran Klein you just
`
`16· · · · mentioned?
`
`17· ·A.· ·Yes.
`
`18· ·Q.· ·In February of 2005, did you know Ran Klein?
`
`19· ·A.· ·February, 2005, I'll have to think about that for a
`
`20· · · · minute.
`
`21· · · · · · · · · ·No, I did not know Ran Klein at that time.
`
`22· ·Q.· ·So let me help you, and I know you said that, so if
`
`23· · · · you go back to page 3 and paragraph 5, and actually
`
`24· · · · this is your sentence.· In the first sentence you say:
`
`25· · · · "I have personal experience working with rubidium-82
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`10
`
`·1· · · · elution systems.· I first started working with
`
`·2· · · · rubidium-82 elution systems during my time at Brigham
`
`·3· · · · and Women's Hospital which began in July of 2008.
`
`·4· · · · · · · · · ·Do you see that?
`
`·5· ·A.· ·Correct.
`
`·6· ·Q.· ·So would that also refresh your recollection that you
`
`·7· · · · did not know Ran Klein at the time of February, 2005?
`
`·8· ·A.· ·Yeah, that is correct, I did not know him at that
`
`·9· · · · time.
`
`10· ·Q.· ·If we go forward, when did you first become aware of
`
`11· · · · the Klein document that you refer to in paragraph 11?
`
`12· ·A.· ·You know, it would be hard for me to put an exact date
`
`13· · · · on that because I've seen work related to this
`
`14· · · · presented in multiple ways, both in, like I said, in
`
`15· · · · presentation format at various talks at meetings.· So
`
`16· · · · I honestly don't know exactly when I became aware of
`
`17· · · · his Master's thesis.· I think that's his Master's
`
`18· · · · thesis.
`
`19· ·Q.· ·Would you say it would be probably after 2010?
`
`20· ·A.· ·I honestly don't know when I would have been aware of
`
`21· · · · that.
`
`22· ·Q.· ·Okay.· In paragraph 11, you refer to the Klein
`
`23· · · · publication.· Were you provided a copy of the Klein
`
`24· · · · publication, or did you provide your attorneys a copy
`
`25· · · · and discuss it in this Declaration?
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`11
`
`·1· ·A.· ·My recollection on that is not 100% clear.· My sense
`
`·2· · · · is that they provided me a copy, but I may have
`
`·3· · · · already had one in my files somewhere as well, but I'm
`
`·4· · · · not 100% sure about that.
`
`·5· ·Q.· ·Have you ever been at a lecture where Ran Klein
`
`·6· · · · presented on this document referred to in paragraph
`
`·7· · · · 11?
`
`·8· ·A.· ·I've been at a number of lectures given by Ran Klein
`
`·9· · · · and his colleagues from Ottawa Heart Institute and
`
`10· · · · elsewhere where material that was in this document has
`
`11· · · · been shown.
`
`12· ·Q.· ·Would you say that your relationship with Ran Klein is
`
`13· · · · someone you see on a frequent basis?
`
`14· ·A.· ·Well, clarify what you mean by frequent.
`
`15· ·Q.· ·Yes, that's fine.· So you attend major symposiums and
`
`16· · · · conferences on a regular basis in your area?
`
`17· ·A.· ·I generally will attend the two major nuclear
`
`18· · · · cardiology meetings annually.· Those are the Society
`
`19· · · · of Nuclear Medicine annual meeting which generally is
`
`20· · · · in June of every year and the American Society of
`
`21· · · · Nuclear Cardiology meeting which is typically in
`
`22· · · · September or October.· In those fora, I would say Ran
`
`23· · · · Klein usually attends at least one of those.· I would
`
`24· · · · say that the likelihood of me seeing him at one of
`
`25· · · · those meetings, which thousands of people attend,
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`12
`
`·1· · · · 50/50 approximately.
`
`·2· ·Q.· ·Did you have occasion to talk to Ran Klein about his
`
`·3· · · · thesis with regard to the present case?
`
`·4· ·A.· ·No.
`
`·5· ·Q.· ·Did you discuss with Ran Klein his thesis and the
`
`·6· · · · patient population that he treated in his thesis?
`
`·7· ·A.· ·Ran is not a physician, so I'm not aware that he
`
`·8· · · · treated patients.
`
`·9· ·Q.· ·Excellent point.· Let me rephrase it.
`
`10· · · · · · · · · ·So as I understand, the Ran Klein let's say
`
`11· · · · system was used on a patient population, is that
`
`12· · · · correct, that he discusses in his thesis?
`
`13· ·A.· ·I don't recall the details of the patient population
`
`14· · · · at this moment.· I'd have to refresh my memory.
`
`15· ·Q.· ·Okay.
`
`16· ·A.· ·But I think you're right that there is some discussion
`
`17· · · · of clinical validation in there.
`
`18· ·Q.· ·Okay.· Have you worked with Ran Klein on designing
`
`19· · · · systems in the profusions area?
`
`20· ·A.· ·No, I don't think I've ever directly collaborated with
`
`21· · · · Ran Klein on the design of profusion systems of any
`
`22· · · · kind.
`
`23· ·Q.· ·Are you aware -- strike that.
`
`24· · · · · · · · · ·Did you have discussions with Ran Klein
`
`25· · · · regarding the system that's disclosed in his February,
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`13
`
`·1· · · · 2005, publication and whether Ran Klein further worked
`
`·2· · · · on that system?
`
`·3· ·A.· ·I'm sorry, can you rephrase that?· I'm a little
`
`·4· · · · confused.
`
`·5· · · · · · · · · ·MR. SCHINDLER:· Can you repeat the
`
`·6· · · · question.
`
`·7· · · · · · · · · ·(The requested portion of the record was
`
`·8· · · · · · · · · ·read by the reporter at 9:16 a.m. as
`
`·9· · · · · · · · · ·follows:
`
`10· · · · · · · · · ·"Question:· Did you have discussions with
`
`11· · · · · · · · · ·Ran Klein regarding the system that's
`
`12· · · · · · · · · ·disclosed in his February, 2005,
`
`13· · · · · · · · · ·publication and whether Ran Klein further
`
`14· · · · · · · · · ·worked on that system?")
`
`15· · · · · · · · · ·THE WITNESS:· I don't recall ever talking
`
`16· · · · to Ran about the design or iteration of the system.
`
`17· · · · We talked about at some points technical merits of it,
`
`18· · · · and prior to its being available in the US market, I
`
`19· · · · think I talked to him about what the plans were for
`
`20· · · · bringing it to the US market, but I don't think I ever
`
`21· · · · talked about iterations on design with him.
`
`22· ·BY MR. SCHINDLER:
`
`23· ·Q.· ·Okay.· Are you aware that he did further iterations on
`
`24· · · · the system that's disclosed in the February, 2005,
`
`25· · · · publication?
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`14
`
`·1· ·A.· ·I know that there were changes made between what was
`
`·2· · · · described in his thesis and the marketed product. I
`
`·3· · · · don't know in detail who was responsible for the
`
`·4· · · · various iterations between.· I did see during the ITC
`
`·5· · · · hearing a number of prototypes that were on, you know,
`
`·6· · · · that had been arranged for other aspects of the case
`
`·7· · · · that I was not directly testifying to, but I'm not
`
`·8· · · · aware of who was responsible for them or what the
`
`·9· · · · differences in detail were between them.
`
`10· ·Q.· ·Okay.· So, again, the focus of mine is your
`
`11· · · · discussions with Ran Klein.
`
`12· ·A.· ·Okay.
`
`13· ·Q.· ·And as I understand, and correct me if I'm wrong,
`
`14· · · · you're stating that you did not have discussions with
`
`15· · · · Ran Klein regarding whether Ran Klein improved the
`
`16· · · · system as disclosed in the February, 2005,
`
`17· · · · publication?
`
`18· ·A.· ·No, I did not have any such discussions.
`
`19· ·Q.· ·And I think I asked this but I'll ask it again. I
`
`20· · · · apologize.
`
`21· · · · · · · · · ·You did not directly work with the system
`
`22· · · · that is detailed in the Ran Klein February, 2005,
`
`23· · · · publication?
`
`24· ·A.· ·If you mean the prototype system that Ran Klein built,
`
`25· · · · no.· I've used the JDI RUBY-FILL system which I
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`15
`
`·1· · · · believe has many of the same design principles within
`
`·2· · · · it but has been refined and is FDA approved.· The
`
`·3· · · · system that Ran built was not authorized for use in
`
`·4· · · · the United States, and I've never practiced in Canada.
`
`·5· ·Q.· ·Okay.· So let's stay in the August timeframe when you
`
`·6· · · · executed your Declaration.· Prior to executing your
`
`·7· · · · Declaration, did you have any discussions with any
`
`·8· · · · Bracco employee regarding your Declaration?
`
`·9· ·A.· ·You'll have to clarify.
`
`10· ·Q.· ·Okay.
`
`11· ·A.· ·You mean this Declaration or other aspects of the
`
`12· · · · case?
`
`13· ·Q.· ·First this Declaration and then I'm going to go to
`
`14· · · · other aspects of the case.
`
`15· ·A.· ·Okay.· This Declaration I don't recall ever talking to
`
`16· · · · anyone at Bracco.· I inadvertently mentioned that this
`
`17· · · · document was something that was being prepared during
`
`18· · · · my earlier deposition related to the ITC aspects of
`
`19· · · · the case when the Bracco attorney asked me something,
`
`20· · · · I don't remember the details exactly, but some
`
`21· · · · question came up and I let slip that I had recently
`
`22· · · · been working on this, but other than that, I don't
`
`23· · · · think I've spoken directly with anyone at Bracco
`
`24· · · · related to this Declaration.
`
`25· ·Q.· ·Okay.· So up until today in your practice, have you
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`16
`
`·1· · · · had conversations with Bracco employees?
`
`·2· ·A.· ·I've spoken to Bracco employees a number of times.
`
`·3· ·Q.· ·And regarding?
`
`·4· ·A.· ·We used the CardioGen System at University of Michigan
`
`·5· · · · and at Brigham and Women's Hospital where I've worked
`
`·6· · · · since 2008, and in both of those capacities, I had
`
`·7· · · · occasion to interact either as part of training to use
`
`·8· · · · the system correctly, or at Michigan I was involved in
`
`·9· · · · negotiations over renewal of supply agreements, things
`
`10· · · · of this sort.
`
`11· ·Q.· ·Staying in the timeframe of prior to August 14th of
`
`12· · · · 2018, did you review the Petition that was filed in
`
`13· · · · this case?
`
`14· ·A.· ·You're going to have to clarify what Petition means.
`
`15· · · · I'm not familiar with that.
`
`16· ·Q.· ·I'm going to show you a copy of a Petition that is --
`
`17· · · · I'm going to show you a copy of a Petition that says
`
`18· · · · Petition for Inter Partes Review of US Patent
`
`19· · · · 9,299,468 and IPR Number 2018-01450, and my first
`
`20· · · · question is:· Have you seen this document before?
`
`21· ·A.· ·No, I don't believe I've seen this document before.
`
`22· ·Q.· ·Okay.· I'm going to show you also a document marked
`
`23· · · · that is Petition for Inter Partes Review of US Patent
`
`24· · · · Number 9,299,467 and Inter Partes Review Case Number
`
`25· · · · IPR 2018-01449, and I'm going to ask you the same
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`17
`
`·1· · · · question:· Have you seen this document first before?
`
`·2· ·A.· ·I don't believe so.
`
`·3· ·Q.· ·Just take a look at it and see if this refreshes your
`
`·4· · · · recollection.
`
`·5· ·A.· ·I don't believe so.
`
`·6· ·Q.· ·I'm going to show you a Petition for Inter Partes
`
`·7· · · · Review of US Patent Number 9,299,468, it's IPR
`
`·8· · · · 2018-01448, and I'm going to ask you the same
`
`·9· · · · question:· Have you seen this Petition before?
`
`10· ·A.· ·I don't believe I've seen in.
`
`11· ·Q.· ·There's three of them but I'm going to ask you
`
`12· · · · questions, they're all related, but I'm going to ask
`
`13· · · · you questions on this one which is called IPR
`
`14· · · · 2018-01448; do you see that?
`
`15· ·A.· ·Yes.
`
`16· ·Q.· ·I'd like you to turn to page IV, which is right at the
`
`17· · · · beginning, and I'm going to ask you questions, so page
`
`18· · · · IV through VII, and that's a series of exhibit lists,
`
`19· · · · and I'd like you to first look at that list.
`
`20· ·A.· ·Yes.
`
`21· ·Q.· ·Okay.· So to understand why I'm asking this question,
`
`22· · · · and correct me if I'm wrong, in your Declaration, I
`
`23· · · · did not see a paragraph that stated the exhibits that
`
`24· · · · you reviewed in preparation for executing the
`
`25· · · · Declaration other than paragraph 11.· Can you confirm
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`18
`
`·1· · · · that?
`
`·2· ·A.· ·That is the list that you're referring to.
`
`·3· ·Q.· ·So then am I correct that prior to executing this
`
`·4· · · · Declaration, that the only exhibits that you reviewed
`
`·5· · · · was what's stated in paragraph 11?
`
`·6· ·A.· ·The one thing that is missing from paragraph 11 is the
`
`·7· · · · Pharmacopeia document that I made the correction and
`
`·8· · · · the citation to.
`
`·9· ·Q.· ·Okay.
`
`10· ·A.· ·But I also relied on about a decade's worth of
`
`11· · · · experience and knowledge in the field, as well as
`
`12· · · · about a decade's worth of knowledge from documents
`
`13· · · · I've read over the years that I've internalized, as
`
`14· · · · well as from my clinical practice experience.
`
`15· ·Q.· ·Okay.· So, for example, if you go back to the Petition
`
`16· · · · that's on page IV and you see the first exhibit is US
`
`17· · · · Patent Number 9,299,468; do you see that reference?
`
`18· ·A.· ·Yes.
`
`19· ·Q.· ·Did you review that patent?
`
`20· ·A.· ·No.
`
`21· ·Q.· ·Okay.· And I gather if I asked you did you review the
`
`22· · · · Complaint 1002, 1003, you would say no in the ITC?
`
`23· ·A.· ·For clarification, the ITC published a request for
`
`24· · · · commentary that referenced this Complaint.· I may have
`
`25· · · · briefly glanced at it, but I'm not 100% sure it was
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`19
`
`·1· · · · one of the documents I reviewed, because I did write a
`
`·2· · · · letter responding to the ITC's request for comments.
`
`·3· · · · I know I searched for the original Complaint, and I
`
`·4· · · · don't recall whether I reviewed it or not.
`
`·5· ·Q.· ·Okay.· And if you go further down -- and again, what
`
`·6· · · · I'm asking you is prior to August 14th when you
`
`·7· · · · executed your Declaration.· So these questions are
`
`·8· · · · prior to that time.· There is a list of Exhibit 1006,
`
`·9· · · · 1007, 1008, 1009, 1010, 1011 with a statement called
`
`10· · · · about a prosecution history.· Are you aware what the
`
`11· · · · term prosecution history is?
`
`12· ·A.· ·No.
`
`13· ·Q.· ·So have you filed for a patent?
`
`14· ·A.· ·No.
`
`15· ·Q.· ·Okay.· I also want to show you a document that's been
`
`16· · · · previously marked as Jubilant Exhibit 1015, and it's a
`
`17· · · · Declaration of Robert T. Stone.
`
`18· · · · · · · · · ·First question:· At any time have you seen
`
`19· · · · this Declaration?
`
`20· ·A.· ·Not before today.
`
`21· ·Q.· ·Okay.· So in preparation for your deposition, you have
`
`22· · · · not reviewed Robert Stone's Declaration?
`
`23· ·A.· ·No, I don't think so.· I haven't seen this document.
`
`24· ·Q.· ·So at any time prior to today, and take your time
`
`25· · · · looking at this document, have you reviewed Robert
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`20
`
`·1· · · · Stone's Declaration?
`
`·2· · · · · · · · · ·MR. WALKER:· Asked and answered.
`
`·3· · · · · · · · · ·THE WITNESS:· Yeah, this is not a document
`
`·4· · · · I saw before you handed it to me.
`
`·5· ·BY MR. SCHINDLER:
`
`·6· ·Q.· ·Okay.· In Robert Stone's Declaration, he also lists a
`
`·7· · · · series of exhibits that he reviewed, and that's in
`
`·8· · · · particular if you go to paragraph 14 on page 5 and
`
`·9· · · · goes through page 8 --
`
`10· ·A.· ·Okay.
`
`11· ·Q.· ·-- you see he listed a series of exhibits?
`
`12· ·A.· ·Yes.
`
`13· ·Q.· ·Let me ask you, prior to today, have you reviewed your
`
`14· · · · deposition that was taken, the transcript that was
`
`15· · · · taken in the ITC case?
`
`16· ·A.· ·The ITC deposition I did review and make corrections
`
`17· · · · to, yes.
`
`18· ·Q.· ·And you also testified at the ITC hearing, correct?
`
`19· ·A.· ·I did.
`
`20· ·Q.· ·Did you review that transcript?
`
`21· ·A.· ·I have not been given that transcript.· Actually,
`
`22· · · · correction, I may have been given the transcript but I
`
`23· · · · have not reviewed it.· There were a number of emails
`
`24· · · · that went around at that timeframe, and I know some
`
`25· · · · transcripts were attached to them.· I don't know for
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`21
`
`·1· · · · sure whether mine was, and I haven't reviewed it.
`
`·2· ·Q.· ·If you would turn to Exhibit A of your Declaration,
`
`·3· · · · and specifically page 1 of 34 of Exhibit A, and this
`
`·4· · · · lists your education, correct?
`
`·5· ·A.· ·Yes.
`
`·6· ·Q.· ·On page 1?
`
`·7· ·A.· ·Yes.
`
`·8· ·Q.· ·And you have as listed, you have a B.S. and an M.S. in
`
`·9· · · · chemistry?
`
`10· ·A.· ·My Bachelor's is in biology.· My Master's is in
`
`11· · · · chemistry, yes.
`
`12· ·Q.· ·And then from 1996 to 2004, what did you receive?
`
`13· ·A.· ·I was in a joint M.D. and Ph.D. program at Johns
`
`14· · · · Hopkins University.
`
`15· ·Q.· ·And you received a degree in?
`
`16· ·A.· ·I received a Doctor of Medicine Degree, and that was
`
`17· · · · in 2004, and I had a little bit earlier than that
`
`18· · · · completed the requirements for my Ph.D. Degree in
`
`19· · · · Biophysics and Biophysical Chemistry, and that was in
`
`20· · · · 2001 that I was awarded that degree.
`
`21· ·Q.· ·And in 2004 to 2005, you had an internship?
`
`22· ·A.· ·That's right.
`
`23· ·Q.· ·All right.· And in 2005 to 2006, you had a radiology
`
`24· · · · residency?
`
`25· ·A.· ·That was one year out of what's typically a four-year
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`22
`
`·1· · · · radiology training curriculum.
`
`·2· ·Q.· ·And then 2006 to 2008, you had a medicine residency.
`
`·3· · · · What areas was that in?
`
`·4· ·A.· ·That was general internal medicine.
`
`·5· ·Q.· ·And then starting in, as you stated previously in your
`
`·6· · · · Declaration, in June of 2008, you started at Brigham
`
`·7· · · · and Women's Hospital, a cardiovascular medicine
`
`·8· · · · fellowship?
`
`·9· ·A.· ·July of 2008, yes.· If I said June, then that was
`
`10· · · · probably in error.
`
`11· ·Q.· ·You said July.· My mistake.
`
`12· ·A.· ·You know these things, the start dates are often
`
`13· · · · sometime between June 20th and July 1st, so, if my
`
`14· · · · memory serves correctly on that case, it was July 1,
`
`15· · · · but I could be off by a couple days.
`
`16· ·Q.· ·So as of 2009, did you have a graduate degree in
`
`17· · · · electrical engineering, system engineering, or
`
`18· · · · mechanical engineering?
`
`19· ·A.· ·No.
`
`20· ·Q.· ·As of 2009, did you have an undergraduate degree in
`
`21· · · · electrical engineering, system engineering, or
`
`22· · · · mechanical engineering?
`
`23· ·A.· ·No.
`
`24· ·Q.· ·As of 2009, would you agree you lacked the education
`
`25· · · · and experience to develop hardware and software
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`23
`
`·1· · · · controls for computer control systems of rubidium-82
`
`·2· · · · elution system?
`
`·3· ·A.· ·Could you repeat that question?
`
`·4· · · · · · · · · ·MR. SCHINDLER:· Yes, can you repeat that.
`
`·5· · · · · · · · · ·(The requested portion of the record was
`
`·6· · · · · · · · · ·read by the reporter at 9:34 a.m. as
`
`·7· · · · · · · · · ·follows:
`
`·8· · · · · · · · · ·"Question:· As of 2009, would you agree you
`
`·9· · · · · · · · · ·lacked the education and experience to
`
`10· · · · · · · · · ·develop hardware and software controls for
`
`11· · · · · · · · · ·computer control systems of rubidium-82
`
`12· · · · · · · · · ·elution system?")
`
`13· · · · · · · · · ·THE WITNESS:· I think I had some knowledge
`
`14· · · · to contribute to such an endeavor, but I certainly
`
`15· · · · couldn't lead a project like that.
`
`16· ·BY MR. SCHINDLER:
`
`17· ·Q.· ·As of 2009, did you develop hardware controls for
`
`18· · · · computer control systems for rubidium-82 elution
`
`19· · · · system?
`
`20· ·A.· ·No.
`
`21· ·Q.· ·Did you develop software controls as of 2009 for
`
`22· · · · computer control systems of rubidium-82 elution
`
`23· · · · system?
`
`24· ·A.· ·No.
`
`25· ·Q.· ·As of 2009, did you have the education and experience
`
`
`U.S. LEGAL SUPPORTU.S. LEGAL SUPPORT
`
`(877) 479-2484(877) 479-2484
`
`YVer1f
`
`

`

`
`Venkatesh Murthy, M.D.Venkatesh Murthy, M.D.
`
`May 23, 2019May 23, 2019
`
`24
`
`·1· · · · to design radiation shielding?
`
`·2· ·A.· ·In 2009, I had training in the general principles of
`
`·3· · · · why mesh shielding is necessary to prevent damage to
`
`·4· · · · cells and to reduce risk of developing cancer for
`
`·5· · · · patients and workers in terms of I have been trained
`
`·6· · · · in the general principles of how shielding should be
`
`·7· · · · arranged and the thickness and material properties
`
`·8· · · · required for different types of radiation protection,
`
`·9· · · · but I was trained as a user in those regards and as a
`
`10· · · · -- my training was to select the appropriate materials
`
`11· · · · and products for clinical use and not necessarily to
`
`12· · · · design them as a manufacturer or engineer.
`
`13· ·Q.· ·So as I understand, you start in July of 2008 with
`
`14· · · · Brigham and Women's Hospital, correct?
`
`15· ·A.· ·That's right.
`
`16· ·Q.· ·And that was the first time that you had any
`
`17· · · · experience with rubidium-82 elution system?
`
`18· ·A.· ·That's correct.
`
`19· ·Q.· ·So by, let's say, January of 2009, you then had
`
`20· · · · sufficient experience to design radiation shielding
`
`21· · · · for rubidium-82 elution system?
`
`22· ·A.· ·No, that's not what I said.· I think I said that I had
`
`23· · · · been trained in the general principl

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket